Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

VanEck Egypt Index ETF (EGPT)

NYSEArca - Nasdaq Real Time Price. Currency in USD
Add to watchlist
20.93-0.20 (-0.95%)
At close: 02:26PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Previous Close21.13
Open21.19
Bid20.49 x 1800
Ask24.57 x 3000
Day's Range20.62 - 21.24
52 Week Range20.11 - 27.78
Volume24,300
Avg. Volume16,519
Net Assets17.12M
NAV21.25
PE Ratio (TTM)N/A
Yield2.59%
YTD Daily Total Return-21.74%
Beta (5Y Monthly)0.87
Expense Ratio (net)1.02%
Inception Date2010-02-16
  • PR Newswire

    Lucid Diagnostics Selects Veeva Vault CDMS for EsoGuard® Study

    Veeva Systems (NYSE: VEEV) today announced that Lucid Diagnostics Inc. (Nasdaq: LUCD), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ), has selected Veeva Vault CDMS to provide electronic data capture (EDC), coding, and data cleaning in their upcoming study for EsoGuard in patients undergoing standard of care screening for, and management of, Barrett's esophagus or esophageal adenocarcinoma.

  • GlobeNewswire

    PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit

    NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced a procedural update on its settlement of a previously disclosed class action lawsuit. As previously disclosed, on January 28, 2021, the Company entered into a term sheet agreement for the settlement of a previously disclosed putative class action lawsuit commenced in November 2020, captioned Spritzer v. PAVmed Inc.,

  • ETF.com

    Sanctions Throw ETF Custody Into New Territory

    The latest sanctions on Russia’s central bank are leaving custodians with tough questions.

Advertisement
Advertisement